The RADIANCE CED Study
The Recor Paradise System™ Hypertension Coverage With Evidence Development Study
ReCor Medical, Inc.
1,000 participants
Nov 21, 2025
OBSERVATIONAL
Conditions
Summary
The RADIANCE CED study is a prospective observational study designed to evaluate the long-term effectiveness of ultrasound renal denervation in lowering blood pressure among patients with uncontrolled hypertension. Data will be collected from electronic health records (EHRs) of Medicare-eligible patients to support generalizability of outcomes to the broader Medicare population. Individual hospital enrollment is not required for this study and IRB exemption has been received by sponsor.
Eligibility
Inclusion Criteria2
- Adults aged ≥65 years with uncontrolled hypertension
- Stable regimen of blood pressure-lowering medication
Exclusion Criteria4
- Hypertension due to secondary causes
- Prior renal denervation treatment
- Pregnancy
- End-stage renal disease, dialysis, or kidney transplant
Interventions
A catheter-based system that delivers ultrasound energy to the renal sympathetic nerves.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07231757